Search

everythinglearnresearchcommunity

for

Search:↓

Current treatments for Alopecia Areata have mixed success, and there's a need for better, more accessible options and support for affected individuals.

AFM can diagnose hair disorders by revealing detailed hair surface changes.

LC-OCT helps accurately diagnose different types of infant hair loss without invasive methods.

Baseline severity, disease activity, and relapse history are key to predicting response and recurrence in alopecia areata.

FLRG and follistatin have different roles in wound healing.

The guideline provides recommendations for managing alopecia areata effectively.

A baby was diagnosed with IFAP syndrome due to a new genetic mutation, showing severe skin and developmental issues.

Alopecia areata treatment varies, with no optimal method established yet.

The Brazilian version of the Alopecia Areata Quality of Life Index is reliable for assessing patients' quality of life.

Apremilast may help treat hair loss in alopecia areata.

Acupuncture and herbal treatments effectively reduced hair loss in androgenetic alopecia.

New treatments targeting the JAK signaling pathway, especially JAK inhibitors, show promise for alopecia areata.

Apremilast was not effective in treating moderate-to-severe alopecia areata.

Dual-targeting therapies like Janus kinase inhibitors may treat both alopecia areata and other immune diseases.

Alopecia Areata is an autoimmune disease causing hair loss in patches, often starting before age 20, and while some cases recover on their own, treatments include topical corticosteroids, minoxidil, and promising new methods like IL-31 antibodies and 308-nm Excimer laser therapy.

Horizontal scalp biopsy sections are better for diagnosing alopecia areata, showing fewer hair follicles and more miniaturized hairs.

AI can improve alopecia areata diagnosis with high accuracy.

Alopecia areata is linked to immune-related genes, suggesting JAK inhibitors as a potential treatment.

Intralesional triamcinolone acetonide is more effective than platelet-rich plasma for treating scalp alopecia areata.

imTA and pulse therapy are effective for alopecia areata with manageable side effects, but relapse rates need improvement.

OCT can detect hidden hair follicles in alopecia areata, indicating potential hair regrowth.

Alopecia areata affects quality of life more in adolescents than adults.

The superficial temporal artery flap is a reliable method for reconstructing complex facial defects with minimal complications.

Some treatments can stabilize Frontal Fibrosing Alopecia, but more research is needed to find effective treatments, and hair transplants often fail.

Hair transplants can trigger a rare scarring hair loss that is hard to treat.

People with Alopecia Areata and Androgenic Alopecia have more mast cells in their scalp than healthy individuals, especially those with Alopecia Areata.

Teriflunomide is an effective and safe first-line oral treatment for relapsing multiple sclerosis.

Many treatments for alopecia areata have inconsistent results; for under 10s, use minoxidil with a corticosteroid, and for over 10s, add ILC and consider diphenylcyclopropenone for widespread cases.

Adding antihistamines to topical corticosteroid and cryotherapy may improve hair regrowth in alopecia areata patients.

Alopecia Areata Incognita causes sudden hair loss in young females but usually has a better outcome than other types.